All biopharmaceutical products must undergo rigorous validation to demonstrate that the manufacturing process is capable of consistently producing a product meeting its predetermined specifications and quality criteria. Regulatory agencies like the FDA require pharmaceutical companies to have a formal process validation protocol in place and conduct validation at defined stages of development. The main goal of these requirements is to establish documented evidence that the bioprocess validation is robust and reproducible through successive commercial production runs.

Protocol Design and Qualification Activities

The validation protocol forms the blueprint for all Bioprocess Validation activities. It identifies all critical process parameters and materials attributes to be monitored and defines acceptance criteria. Qualification activities are conducted to prove the suitability of facilities, utilities, and equipment for the intended manufacturing process. This includes facility cleaning validation, installation qualification of equipment and utilities, and operational qualification to demonstrate that the equipment performs as intended. Performance qualification then proves the process can consistently deliver quality products meeting all requirements.

Process Characterization and Development of CPPs

Thorough process characterization is needed to understand all factors potentially influencing product quality. This involves designing experiments to identify any parameters having a significant effect on critical quality attributes. Acceptable ranges (limits) are then established for all identified critical process parameters (CPPs) to ensure the process remains in a state of control. Relationships between CPPs and quality attributes are also determined to facilitate process understanding and control strategy development.

Media and Buffer Preparation

Media and buffers form the backbone of cell culture and downstream purification processes. Their preparation involves the use of water, which must undergo purification via processes like reverse osmosis, deionization, and filtration. Media components are added in a specified sequence and concentrations confirmed. Prepared lots are subjected to testing like sterility, endotoxin levels, and biochemical characterization to ensure consistency and quality. Appropriate hold times and storage conditions are also validated.

Get more insights on Bioprocess Validation